Hawazin Faruki
Profile
Hawazin Faruki worked as the Chief Scientific Officer at GeneCentric Therapeutics, Inc. in a former job.
She obtained an undergraduate degree from Washington University in St. Louis and a doctorate degree from North Carolina State University in her education history.
Former positions of Hawazin Faruki
| Companies | Position | End |
|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | 09/09/2018 |
Training of Hawazin Faruki
| North Carolina State University | Doctorate Degree |
| Washington University in St. Louis | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Hawazin Faruki
